Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
biotech
clinical trials
fda
life sciences
national
national blog main
national top stories
new york top stories
san francisco top stories
spinal muscular atrophy
spinraza
2
×
89bio
abbvie
adrian krainer
alexion pharmaceuticals
alzheimer europe conference
alzheimer's disease
astrazeneca
bain capital
billy dunn
biotech ipos
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
cerevel therapeutics
convergence pharmaceuticals
crispr therapeutics
cystic fibrosis
detroit blog main
detroit top stories
dicerna pharmaceuticals
drug prices
drug pricing
drugs
ed kaye
What
drug
2
×
alzheimer’s
annual
approved
assessed
atrophy
attention
bio
biotech
communities
conference
daily
esmo
europe
evrysdi
fda
friday
germany
green
home
hosted
intended
investment
lights
liquid
medicine
munich
muscular
new
oral
patients
prices
puzzle
research
risdiplam
roche
roundup
spinal
therapy
turned
Language
unset
Current search:
spinraza
×
drug
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More